Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0002028640-26-000002

Director sold 50 shares at $460.98 ($23,049)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MALCOLM JAN Director 2026-01-16 Sale 10b5-1 −50 $460.98 $23,049 320 D: show line 1 in the form
Open-market sales · 50 sh · avg $460.98 · $23,049
Loading xslF345X05/primarydocument.xml…